Compounding Sources

A US pharmacy label tells you who dispensed the vial. It does not tell you where the peptide was made. The ingredient can travel through manufacturers and distributors before a pharmacy turns it into a finished preparation.

The 2024 Red Rock Pharmacy correspondence below puts names to that chain: Genohope and Alvantis, both Chinese suppliers, appear alongside specific dispensed lots. That is a useful finding. The next question is what happened between the ingredient and the vial in someone's hand.

• Follow the names — two supplier certificates and the pharmacy's replies. See the documents ↓
• Decode the powder — raw API, base, salt and lyo describe different things. Compare the forms ↓
• Check the claim — turn “same factory” into questions someone can answer. Use the checklist ↓

Where do compounding pharmacies get their tirzepatide?#

They can buy the active pharmaceutical ingredient, or API, from an ingredient manufacturer or through a distributor. The pharmacy's name and the original manufacturer's name may be different. Here is the route to ask about:

1. Make the ingredient
   An API manufacturer produces the peptide and assigns a batch number.
2. Move the ingredient
   A distributor or repackager may handle it before it reaches the compounder.
3. Make the finished vial
   The compounder formulates, prepares and checks the product it dispenses.

Buyer's takeaway: ask who made the API, then ask who prepared the finished product. A domestic shipping address answers neither question. FDA's supplier-traceability guidance also tells compounders to identify the original manufacturer and check their suppliers.

What do 503A and 503B mean?#

503A generally means compounding for an identified patient with a prescription. 503B outsourcing facilities can also supply healthcare providers without an individual patient's prescription and must follow current good manufacturing practice requirements. Neither designation makes a compounded drug FDA-approved. The two frameworks

Which Chinese suppliers appear in the pharmacy records?#

The November 4, 2024 reply lists Genohope for dispensed lot 102205CH and Alvantis for 091702CH. The supplier COAs below identify their own API lots. Keep both sets of numbers: an ingredient batch and a pharmacy's finished batch are different records.

The useful detail is bigger than “Chinese powder”: an ingredient COA and a finished-vial test answer different questions. A supplier's purity result is the starting point. Ask the pharmacy for the finished-batch results too. Testing 101: read a COA

What did Red Rock say about its raw API and finished batches?#

These two replies answer the questions people actually ask: who supplied the ingredient, and what did the pharmacy do with it? Each dated excerpt is followed by readable text.

November 4, 2024: Genohope and Alvantis#

Batch details transcribed from the email

Genohope brand — tirzepatide 20 mg/mL; lot 102205CH; 2.5 mL; filled October 22, 2024.

Alvantis brand — tirzepatide 20 mg/mL; lot 091702CH; 2 mL; filled September 17, 2024.

December 24, 2024: raw powder, preparation and base form#

Red Rock Pharmacy's reply · selected verbatim excerpts

“We compound using the raw powder sourced from an FDA inspected manufacturer.”

“It is the base form of the API.”

In plain English: the pharmacy says it buys raw API, makes its liquid formulation, sterilizes the medication and sends each finished batch to a third-party lab. The inspection description above is the pharmacy's statement in its 2024 reply.

The question to borrow: “Can you provide the ingredient report and the test results for the finished batch I received?” These archived replies are useful examples of the detail to request for a current order.

Raw API vs. lyophilized powder: why do the vials look different?#

Why does a pharmacy buy raw powder while you receive a little puck? They are buying for different next steps. A compounder buys an ingredient to turn into a measured liquid preparation under controlled conditions. A seller offering individual dry vials supplies a product that still needs liquid added before it becomes a solution. Drying can help storage stability; the actual formulation and shipping conditions still matter.

The confusing bit is the listing language. “Base” tells you about the chemical form; “lyo” tells you about drying. You can describe one material with both terms. Here is the group-chat translation:

• Raw API = the ingredient
  Bulk material bought for further formulation. It is not a finished, ready-to-inject medicine.
• Base or salt = the chemical form
  Ask which form is in the vial. You cannot read that answer from the shape of the powder.
• Lyo = freeze-dried
  Water has been removed to leave a dry cake or powder. “Lyo” alone does not tell you whether it is base or salt.

Where does mannitol fit in? It is an extra formulation ingredient that can help build the cake. Some products use it; others use different ingredients. Neither mannitol nor conversion to a salt is a mandatory step for every freeze-dried peptide. Ask what is actually in your vial. Freeze-drying basics

There is no automatic “two months at room temperature” allowance. The Alvantis certificate above actually specifies frozen storage. Ask for storage and shipping evidence for the particular material. A pharmacy's liquid and a home-reconstituted vial can also differ in concentration, ingredients, pH and storage life; copying the pharmacy's use-by date skips those differences.

Compounded medicine vs. a gray-market research vial#

Same country is not the same product. Even a shared API manufacturer would leave formulation, handling, filling, testing and storage to compare. Judge those steps on evidence, not a reassuring factory name.

For the practical follow-ups, use Lyophilized Peptides: visual red flags, Dictionary: counterions and Residual Solvents: TFA and solvent tests.

What do the China and US labeler charts actually tell us?#

The useful reveal: an American pharmacy label can sit at the end of a Chinese API supply chain. The Red Rock replies give this story actual supplier names. In the 2024 chart below, China also has the largest group of listed names: 20, compared with 8 in the US and 1 in India.

Read past the name on the label. A labeler can make the ingredient, repackage it or put its name on the product. Ask which role the company performs and where the original factory is. FDA listing is not product approval. How the NDC Directory works

How did the recorded labeler names change?#

What should I ask before trusting “the same source”?#

Keep it short. A useful answer has names, batch numbers and documents:

1. Who actually made it? Get the API manufacturer's legal name, manufacturing site and batch number. Separate the factory from the distributor.
2. Where is the batch link? Match the ingredient lot to the finished vial or kit. A familiar company name on an unrelated COA is not the missing link.
3. What happened after manufacture? Ask who formulated, filled and sealed the vials, and which ingredients were added.
4. What was tested? Ask for complete reports and verification details. Distinguish raw-ingredient results from finished-product results.
5. What supports storage and shipping? Get the specified conditions and the evidence behind the expiry or use-by date. “Lyo ships fine” is not a temperature record.

💬 A message you can send

Please identify the original API manufacturer and ingredient lot for this batch. Can you share the complete API COA, the link to my finished-vial lot, the formulation details and the finished-batch test results? Please also confirm the storage and shipping conditions.

If the answer stops at “pharmacy grade” or “same factory,” the useful details are still missing. Pause the purchase rather than paying extra for a claim nobody will document.

Continue reading#

• Testing 101: verify a COA — check the document before trusting the claim.
• Gray 101: finding a vendor — take the supplier questions into your wider research.
• All guides and posts — return to the full library.